PRO overlap statistics ranged from 0.52 to 0.59 and from 0.60 to 0.70 for randomly selected patients with high versus medium and low BSA, respectively, indicating patients with high and medium BSA are likely to have similar levels of disease burden, and patients with high BSA are slightly more likely to have higher disease burden than those with low BSA
Canadian customs may seize imported peptides, though enforcement varies
There remains a significant need for validation in humans, especially concerning muscle strength, said co-first author Takuya Karasawa, PhD
More serious risks include: Low blood sugar (hypoglycemia): Especially when used with other medicines to treat diabetes, low blood sugar may occur, with symptoms such as dizziness, sweating, blurred vision, or confusion